abstract |
The present invention relates to 1-aza-bicycloalkyl derivatives of the formula I: wherein X is CH2 or an individual bond; And it is a group of the formula: and where R has the meanings defined in the specification, whose compounds are agonists of the nicotinic acetylcholine receptor alpha-7 (nAChR); to processes for their production, to their use as pharmaceutical products, and to pharmaceutical compositions that comprise them. |